Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$8.9B
66M shares
52-week range
$23.30 – $155.44
86% from low
Sector
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Exchange
NASDAQ
CS
P/S (TTM)
19.8
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
www.twistbioscience.comNo one on the platform currently holds TWST.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2025-06-30 | 13,800 | $507.7K |
No one on the platform has traded TWST yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| Rev. Growth % | 20.3% | 33.1% | ||||
| Profit Margin % | -20.6% | -78.6% | -352.0% | |||
| Free Cash Flow Margin % | -20.1% | -65.6% | -347.4% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$TWST From the FREE video. Mentioned as a buy near 124 support. Now up 10 points from there!
View on StockTwits ↗$TWST watching a few Bios into next week... this one , watching got a turn > 20d MA
View on StockTwits ↗
$TWST Twist Bioscience stock watch, nice trend with a pullback to 125.04 support area and high trade quality at https://www.stockconsultant.com/?TWST Long Trade Target 1: 149.59 Profit: 17.9% Stop/Trailing Stop: 120.38 Loss: 5.1% P/L ratio: 3.5 : 1 - Good Target 2: 161.37 Profit: 27.2% P/L ratio: 5.3 : 1 - Excellent Extreme rally BULLISH [Positioning] at support [Timing] Strong bullish 3 day candlestick pattern with Strong 3 day accumulation. [Timing] Excellent long trade quality BEARISH [Positioning] Intermediate trend possibly bearish, Uptrend turned sideways, may continue or pullback.
View on StockTwits ↗
I added $TWST to the Greens List last night. Another bullish setup. Note the MACD pinch giving us our "early" signal. On watch for entry today in the Live Trading Room.
View on StockTwits ↗
Synthetic DNA for training data sets in AI led Drug Discovery : Twist Bioscience $TWST, Azenta $AZTA, DNA Script, GenScript, Danaher $DHR, Illumina $ILMN
View on StockTwits ↗
$TWST I knew scorpian capital were onto something...Insiders been selling like crazy. Emily (who looks/sounds like a tranny) is dumping . This will.be another spectacular synbio pump and dump.
View on StockTwits ↗
$TWST Settlement FAQ: Who’s Eligible for the $17.05M? Q: What happened? A: Twist Bioscience was accused of overstating the automation, quality, and profitability of its synthetic DNA and NGS business. After a November 2022 short-seller report challenged those claims, $TWST fell 20% in one day. Q: Am I actually eligible? A: If you bought $TWST shares between 2018 and 2022, you’re likely eligible. You don’t need to hold the stock still to claim; past losses count Q: When do payouts happen? A: Typically, within 4–9 months after the claim deadline. But the exact timing depends on the court and settlement administration. Check if you're eligible and file a claim: https://11th.com/cases/twist-investor-settlement
View on StockTwits ↗
$TWST from 155 to 125--30 point drop--dead fking money--boy was I ever lucky getting out at 150---great company though --plenty of cash but not with a 30 point drop--had a great run though until now
View on StockTwits ↗
@IsabellaDC @Jblack500 @WAJeff @cynicaloptimist @BustaCapital $NTRA $RVTY $TWST ing
View on StockTwits ↗
$TXG This and $TWST just went off without much fanfare. TXG beyond my wildest expectations.
View on StockTwits ↗
$PACB de novo accuracy will be the most important thing for data to train genomic llms $TWST
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $456M | +21.8% | $-2.16 | $-2.22–$-2.03 | — | 4 |
| 2027 | $544M | +19.3% | $-1.37 | $-1.41–$-1.28 | — | 4 |
| 2028 | $636M | +16.8% | $-0.83 | $-1.38–$-0.45 | — | 7 |
| 2029 | $774M | +21.8% | $0.35 | $0.33–$0.36 | 394.8× | 2 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 4 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-03 | $-0.51 | $-0.56 | -10.6% |
| 2026-05-04 | $-0.49 | $-0.71 | -44.9% |
| 2026-02-02 | $-0.48 | $-0.50 | -4.2% |
| 2025-11-14 | $-0.50 | $-0.45 | +10.0% |
| 2025-08-04 | $-0.54 | $-0.47 | +13.0% |
| 2025-05-05 | $-0.56 | $-0.66 | -17.9% |
| 2025-02-03 | $-0.62 | $-0.53 | +14.5% |
| 2024-11-18 | $-0.71 |
| $-0.59 |
| +17.4% |
| $2.2B |
| — |
| GRDNGuardian Pharmacy Services, Inc. | $46.49 | +6.53% | $2.9B | — |
| MESOMesoblast Limited | $15.02 | -2.97% | $1.9B | — |
Source: Financial Modeling Prep · peers by sector/industry